Impact of the Normalized Copy Number of <i>BCR-ABL</i> Transcript upon Diagnosis on Prognosis in CML Patients Treated with Imatinib-Mesylate
Open Journal of Blood Diseases · 2011
DOI: 10.4236/ojbd.2011.12004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Journal of Blood Diseases, 2011. Verfasst von Christophe Martinaud und 6 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Martinaud, C., Mayet, A., Bousquet, S., Beaufils, N., Gabert, J., Raynaud, S., & Mozziconacci, M. (2011). Impact of the Normalized Copy Number of BCR-ABL Transcript upon Diagnosis on Prognosis in CML Patients Treated with Imatinib-Mesylate. Open Journal of Blood Diseases. https://doi.org/10.4236/ojbd.2011.12004
Vancouver
Martinaud C, Mayet A, Bousquet S, Beaufils N, Gabert J, Raynaud S, et al. Impact of the Normalized Copy Number of BCR-ABL Transcript upon Diagnosis on Prognosis in CML Patients Treated with Imatinib-Mesylate. Open Journal of Blood Diseases. 2011. doi:10.4236/ojbd.2011.12004
BibTeX
@article{Martinaud2011,
author = {Martinaud, Christophe and Mayet, Aurélie and Bousquet, Sophie and Beaufils, Nathalie and Gabert, Jean and Raynaud, Sophie and Mozziconacci, Marie-Joelle},
title = {Impact of the Normalized Copy Number of BCR-ABL Transcript upon Diagnosis on Prognosis in CML Patients Treated with Imatinib-Mesylate},
journal = {Open Journal of Blood Diseases},
year = {2011},
doi = {10.4236/ojbd.2011.12004}
}
EUVIMED